SN Share Price

Open 1144.00 Change Price %
High 1170.00 1 Day 38.33 3.39
Low 1144.00 1 Week 51.33 4.60
Close 1168.33 1 Month 45.33 4.04
Volume 3230129 1 Year 77.33 7.09
52 Week High 1324.00
52 Week Low 1040.36
SN Important Levels
Resistance 2 1192.43
Resistance 1 1182.50
Pivot 1160.78
Support 1 1154.16
Support 2 1144.23
LON UK Most Active Stocks
CWC 74.60 0.27%
CWC 74.60 0.27%
CWC 74.60 0.27%
INC 0.04 -20.00%
LLOY 61.89 -1.40%
LGO 0.13 -7.14%
LGO 0.13 -7.14%
LGO 0.13 -7.14%
AFPO 0.06 20.00%
REX 645.08 0.01%
More..
LON UK Top Gainers Stocks
AKT 28.50 5177.78%
HHR 58.00 900.00%
MES 0.28 75.00%
MES 0.28 75.00%
MES 0.28 75.00%
PFLM 5.75 64.29%
BAC 22.93 63.79%
BAC 22.93 63.79%
BAC 22.93 63.79%
GEC 29.83 57.00%
More..
LON UK Top Losers Stocks
ENDV 0.02 -99.85%
KEA 0.10 -91.30%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
DCP 0.50 -75.61%
FRP 20.91 -60.17%
FRP 20.91 -60.17%
PCI 3.50 -53.27%
PCI 3.50 -53.27%
More..

Smith & Nephew PLC (LON: SN)

SN Technical Analysis 3
As on 9th Dec 2016 SN Share Price closed @ 1168.33 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1181.79 & Sell for SHORT-TERM with Stoploss of 1169.05 we also expect STOCK to react on Following IMPORTANT LEVELS.
SN Target for December
1st Target up-side 1194.27
2nd Target up-side 1242.83
3rd Target up-side 1291.39
1st Target down-side 1055.73
2nd Target down-side 1007.17
3rd Target down-side 958.61
SN Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.smith-nephew.com
SN Address
SN
15 Adam Street
London, WC2N 6LA
United Kingdom
Phone: 44 20 7401 7646
Fax: 44 20 7930 3353
Interactive Technical Analysis Chart Smith & Nephew PLC ( SN LON UK )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Smith & Nephew PLC
SN Business Profile
Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. The company’s Advanced Surgical Devices segment offers orthopaedic reconstruction implants for hip, knee, and shoulder joints; and ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. It also provides sports medicine products, which offer surgeons an array of instruments, technologies, and implants to perform minimally invasive surgery of the joints, including knee, hip, and shoulder repair; and trauma and extremities products consisting of internal and external devices and other products, including shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures. In addition, this segment provides arthroscopy enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, as well as offers radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissues to healthcare providers. The company’s Advanced Wound Management segment offers a range of initial wound bed preparation and full wound closure products. Its products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers; and products for the treatment of wounds, such as burns and invasive surgery. Smith & Nephew plc primarily serves medical and surgical treatments and service providers. The company was founded in 1856 and is headquartered in London, the United Kingdom.